June 6, 2023 08:50 AM EDTUpdated June 23, 04:16 PM
Pharma
Law

Mer­ck sues US gov­ern­ment over IRA, chal­leng­ing drug pric­ing bill’s con­sti­tu­tion­al­i­ty

Andrew Dunn

Senior Biopharma Correspondent

Mer­ck has filed a law­suit in fed­er­al court to try and in­val­i­date the In­fla­tion Re­duc­tion Act, tak­ing the lead in the phar­ma in­dus­try’s op­po­si­tion to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times